DUBLIN–(BUSINESS WIRE)–The “Single Cell Genomics Markets. Forecasts by Technology, Product, Workflow, User and Country with Executive and Consultant Guides 2023 to 2027” report has been added to ResearchAndMarkets.com’s offering.
Will Single Cell Genomics replace traditional genomics? The sky just might be the limit on this new approach to capturing genetic information. Find out all about it in this new report.
Single Cell Genomics is emerging as a mainstay of scientific research and development. New life forms have already been identified. This means new diseases and new cures.
There are applications in every aspect of healthcare. Just coming out of the lab it is finding its footing in new clinical applications especially related to immune-oncology and microbiology. The market is booming as understanding the genomics of individual cells opens up a whole new world of biotechnology.
This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.
The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.
Market Dynamics
Factors Driving Growth
- Immuno-oncology
- Research Range
- Technology Maturity & Convergence
- Declining Costs
Factors Limiting Growth
- Competition
- Instrument Integration
- Technology Shift
- Technology Limitations
Single Cell Genomics Recent Developments
- Scale Biosciences Introduces Disruptive Single-Cell Profiling Solutions
- Singleron showcases latest single cell sequencing technology
- Oxford Nanopore to Make Single-cell Sequencing Accessible to Any Laboratory
- Single-Cell RNA-seq Method Enables Profiling Live Cells
- Novogene Launches New Single-Cell Lab
- New DNA Atlas Provides Clues for Heart Disease Risk
- BioSkryb Genomics Launches ResolveOME
- Parse Biosciences Expands Single-Cell Product Line
- Massively Multiplexed Single-Cell In Situ Spatial Genomics Now in U.S. Market
- Pfizer Centralizes Single Cell Data on Seven Bridges System
- Consortium to Standardize Single-Cell Sequencing
- Scienion, Cellenion Enter Licensing Deal
- Immunai Acquires Swiss Bioinformatics Firm Nebion
- Startup MiCareo Targets Rare Cell Isolation Market
- Parse Biosciences Lowers Cost Barriers to Single-Cell Transcriptomics
- Deepcell Advancing Tech for Single-Cell Genomics
- 10x Genomics Outlines 2021 Growth Plans
- Single-Cell Genomics Firm Analytical Biosciences Inks Deal with BioMap
- IsoPlexis Features Cheaper, More Flexible Single-Cell Proteomic Systems
- DNTR-Seq Combines WGS, Transcriptomics in Single Cells
- BitBiome Builds Single-Cell Bacterial Sequencing Business
- S2 Genomics Signs Distribution Agreements for Asia-Pacific
- Single-Cell COVID-19 Study Investigates Immune Hyperactivation
- Levitas Bio to Launch Magnetic Levitation Cell Separation Platform
- Single-Cell and Spatial Genomics
- Single-Cell Genomics
- Namocell, Takara Bio, HepaTx Partner on Single-Cell Genomics
- Vizgen Launches With $14M Series A Financing
- SeqWell Raises $9M in Series B Round
Companies Mentioned
- 10x Genomics, Inc.
- 1CellBio
- Agilent/Dako
- Beckman Coulter Diagnostics
- Becton, Dickinson and Company
- Berkley Lights
- BioGenex
- Bio-Rad Laboratories, Inc.
- BioSkryb Genomics
- Bitbiome
- Bruker
- Cell Microsystems
- Cellsee Diagnostics
- CellSorter
- Cytek Biosciences
- Cytena
- Dolomite Bio
- Element Biosciences
- Epic Sciences
- Fluxion Biosciences
- Illumina
- Incell Dx
- Labcyte
- Leica Biosystems
- Menarini Silicon Biosystems
- Miltenyi Biotec
- Mission Bio
- Myllia Biotechnology
- Nanostring
- New England Biolabs, Inc.
- Novogene Bioinformatics Technology Co., Ltd.
- Oxford Nanopore Technologies
- Parse Biosciences
- Perkin Elmer
- Qiagen
- Readcoor
- Roche Molecular Diagnostics
- S2 Genomics
- Scale Biosciences
- Singleron Biotechnologies
- Singular Genomics
- Singulomics
- Sony Biotechnology
- Standard BioTools
- Takara Bio
- Thermo Fisher Scientific Inc.
- Ultima Genomics
- Vizgen
- Watchmaker Genomics
For more information about this report visit https://www.researchandmarkets.com/r/z9vnb1
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
